Chronic pain originating from the musculoskeletal system is a dominant
cause of sick-leave in modern industry and can be a very disabling and
troublesome condition for the individual. Although the cause of this
problem in skeletal muscle is unknown, one of the most frequent
situations in which muscle pain is experienced is in industrial workers
who have to move repeatedly and/or forcibly. The cumulative trauma
disorder (CTD) which results from repetitive movements is of special
interest because these repeat-motion injuries are one of the most
difficult to anticipate and prevent.
Our studies in humans have shown that exposure to a single bout of
repeated strains can lead to myofiber and fascial rupture without
bleeding but accompanied by muscle pain, restricted motion, and loss of
strength and power. Little is known about the effect of repeated strains
on muscles or the dynamic components of repeated use such as velocity and
acceleration which produce injury resulting in CTD or CTD risk. Since
variations in human exposure and response together with the necessity for
repeated tissue sampling makes man unsuitable as a research subject, we
have developed a rodent model of repeated strain injury (CTD).
Using this model, the present study is designed: 1) to determine the
dynamic factors (velocity, acceleration and dose) which produce
dysfunctional versus adaptive muscles, 2) to document changes in the
extracellular matrix and myofibers which lead to a pathologic muscle, and
3) to study the functional outcome and reversibility of repeated injury
at different speeds and accelerations commonly experienced by hand-
intensive industrial jobs. This research consists of experiments in which
muscles are chronically injured by mechanical overloading in deeply
anesthetized rats. The tissues are surveyed at various time intervals
by biochemical, immunohistochemical and histological techniques for
specific cellular markers, components and mediators involved in tissue
injury and repair. The functional outcome of repeated injury is assessed
by in vivo dynamometry; strength, endurance and stiffness are good
measures of muscle performance.
Insight into the dynamic factors producing muscle injury should provide
a better understanding of the healing (adaptive) or failed-healing
(pathologic) processes of muscle and aid in the design of preventative
regimens for individuals in specific industrial settings. The long range
goals are to determine: 1) if diminished muscle shock absorption is an
impOrtant step in the development of clinical CTD; 2) if prevention of
CTD can be implemented by behavioral alterations.
National Institute for Occupational Safety and Health
CFDA Code
DUNS Number
191510239
UEI
M7PNRH24BBM8
Project Start Date
30-September-1995
Project End Date
29-September-1999
Budget Start Date
30-September-1997
Budget End Date
29-September-1998
Project Funding Information for 1997
Total Funding
$196,489
Direct Costs
$137,121
Indirect Costs
$59,368
Year
Funding IC
FY Total Cost by IC
1997
National Institute for Occupational Safety and Health
$196,489
Year
Funding IC
FY Total Cost by IC
Sub Projects
No Sub Projects information available for 5R01OH002918-06
Publications
Publications are associated with projects, but cannot be identified with any particular year of the project or fiscal year of funding. This is due to the continuous and cumulative nature of knowledge generation across the life of a project and the sometimes long and variable publishing timeline. Similarly, for multi-component projects, publications are associated with the parent core project and not with individual sub-projects.
No Publications available for 5R01OH002918-06
Patents
No Patents information available for 5R01OH002918-06
Outcomes
The Project Outcomes shown here are displayed verbatim as submitted by the Principal Investigator (PI) for this award. Any opinions, findings, and conclusions or recommendations expressed are those of the PI and do not necessarily reflect the views of the National Institutes of Health. NIH has not endorsed the content below.
No Outcomes available for 5R01OH002918-06
Clinical Studies
No Clinical Studies information available for 5R01OH002918-06
News and More
Related News Releases
No news release information available for 5R01OH002918-06
History
No Historical information available for 5R01OH002918-06
Similar Projects
No Similar Projects information available for 5R01OH002918-06